MORPh Study Days are ‘spot on’

ByRuby Edwards

Our Study Days in 2017 are ‘spot on’ according to our delegates! We’ve received such great feedback that we thought we’d share it with you :

“The whole day was spot-on, so relevant to my day-to-day practice ..”
“I really enjoyed the mental health study day. The speaker was excellent, quite determined to engage everyone there! He was funny and informative, the perfect speaker ..”
“I really enjoyed the training, very good content ”

In fact, our Study Days are so popular that we’ve expanded our 2018 programme to include Wales and Scotland as well as added some major therapy areas. Each Study Day will be facilitated by a CCG/HB Head of Medicines Management to ensure relevance and all our speakers are experts in their field. More details can be found here.

Similar Posts

The Pharmacy Show

We look forward to meeting you all at The Pharmacy Show on stand PB40 with the PDA on Sunday and Monday. Director Dr Duncan Jenkins is speaking on both days regarding the developmental work which has been carried out in partnership with the PDA, providing a framework for supporting as well as developing competency in primary care…

PDA Plus Partnership

We’re delighted to announce our partnership with the Pharmacist’s Defence Association to provide the delivery of high quality training to Primary Care Pharmacists. Our schedule of Events for the Risk Management Meetings – and all of our other events – can be found here. Dr Duncan Jenkins, Director MORPh, is thrilled by the announcement, stating…

MORPh Market Access Learning Sets

The MORPh Market Access Learning Sets are aimed at pharmaceutical sales and marketing professionals. MORPh Market Access Learning Sets are small round table meetings with about 10-15 delegates. These are not sit and listen events! One of our Directors will Chair the session and look at recent policies or changes in the NHS which may…

The year ahead

We look forward to the year ahead with a feature in the latest issue of the Pf Magazine Check out details on line and read what Dr Duncan Jenkins has to say on p24-25. We will also feature in the next two issues of the leading Pharmaceutical Magazine, so keep checking back for details! 

Leave a Reply